Hippo T&C

HippoT C, established in 2020, is a pioneering startup specializing in the development of advanced digital therapeutics and diagnostic tools using Virtual Reality (VR) and Artificial Intelligence (AI). The company primarily focuses on creating solutions for Attention Deficit Hyperactivity Disorder (ADHD), offering a novel approach to diagnose and measure symptom severity through its patented ADHD severity evaluation system. This system leverages data correlations gathered via VR to provide accurate assessments, which is a significant advancement in the field of mental health diagnostics.

HippoT C operates in the digital health market, targeting healthcare providers, clinics, and medical professionals who require precise and innovative tools for ADHD diagnosis and treatment. The business model revolves around the development and sale of its proprietary software solutions, as well as potential future expansions into other areas such as depression and diabetes treatment. Revenue is generated through software licensing, clinical trial partnerships, and potential medical device approvals.

The startup has garnered recognition for its contributions to digital innovation, including accolades from the 2022 Korea ICT Awards. HippoT C aims to continue its growth by advancing its technology and expanding its therapeutic applications.

Keywords: ADHD, digital therapeutics, VR, AI, mental health, diagnostics, healthcare, software, innovation, medical device.